US Patent Issued to Corcept Therapeutics on May 6 for "Methods for imaging and treatment of somatostatin-receptor positive tumors" (Florida Inventor)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,551, issued on May 6, was assigned to Corcept Therapeutics Inc. (Redwood City, Calif.).

"Methods for imaging and treatment of somatostatin-receptor positive tumors" was invented by Andreas G. Moraitis (Sunny Isles Beach, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating, identifying and localizing tumors expressing somatostatin receptors (SRs), including methods of enhancing the efficacy of imaging techniques by administration of a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator (HKGRM) effective to increase SR expression in tumors. HKGRM administration for enhancing SR-based tumor imaging and treating neu...